• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

运用临床变量聚类分析识别急性心力衰竭的新表型。

Identifying novel phenotypes of acute heart failure using cluster analysis of clinical variables.

机构信息

Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.

Division of Cardiology, Mitsui Memorial Hospital, Tokyo, Japan.

出版信息

Int J Cardiol. 2018 Jul 1;262:57-63. doi: 10.1016/j.ijcard.2018.03.098. Epub 2018 Mar 29.

DOI:10.1016/j.ijcard.2018.03.098
PMID:29622508
Abstract

BACKGROUND

Acute heart failure (AHF) is a heterogeneous disease caused by various cardiovascular (CV) pathophysiology and multiple non-CV comorbidities. We aimed to identify clinically important subgroups to improve our understanding of the pathophysiology of AHF and inform clinical decision-making.

METHODS

We evaluated detailed clinical data of 345 consecutive AHF patients using non-hierarchical cluster analysis of 77 variables, including age, sex, HF etiology, comorbidities, physical findings, laboratory data, electrocardiogram, echocardiogram and treatment during hospitalization. Cox proportional hazards regression analysis was performed to estimate the association between the clusters and clinical outcomes.

RESULTS

Three clusters were identified. Cluster 1 (n=108) represented "vascular failure". This cluster had the highest average systolic blood pressure at admission and lung congestion with type 2 respiratory failure. Cluster 2 (n=89) represented "cardiac and renal failure". They had the lowest ejection fraction (EF) and worst renal function. Cluster 3 (n=148) comprised mostly older patients and had the highest prevalence of atrial fibrillation and preserved EF. Death or HF hospitalization within 12-month occurred in 23% of Cluster 1, 36% of Cluster 2 and 36% of Cluster 3 (p=0.034). Compared with Cluster 1, risk of death or HF hospitalization was 1.74 (95% CI, 1.03-2.95, p=0.037) for Cluster 2 and 1.82 (95% CI, 1.13-2.93, p=0.014) for Cluster 3.

CONCLUSIONS

Cluster analysis may be effective in producing clinically relevant categories of AHF, and may suggest underlying pathophysiology and potential utility in predicting clinical outcomes.

摘要

背景

急性心力衰竭(AHF)是一种由多种心血管(CV)病理生理学和多种非 CV 合并症引起的异质性疾病。我们旨在确定临床上重要的亚组,以提高我们对 AHF 病理生理学的理解并为临床决策提供信息。

方法

我们使用 77 个变量的非层次聚类分析评估了 345 例连续 AHF 患者的详细临床数据,包括年龄、性别、HF 病因、合并症、体格检查、实验室数据、心电图、超声心动图和住院期间的治疗。使用 Cox 比例风险回归分析来估计聚类与临床结局之间的关联。

结果

确定了三个聚类。聚类 1(n=108)代表“血管衰竭”。该聚类在入院时的平均收缩压最高,并且存在 2 型呼吸衰竭伴肺充血。聚类 2(n=89)代表“心脏和肾脏衰竭”。他们的射血分数(EF)最低,肾功能最差。聚类 3(n=148)主要由年龄较大的患者组成,心房颤动和 EF 保留的患病率最高。在 12 个月内死亡或因 HF 住院的患者在聚类 1 中占 23%,在聚类 2 中占 36%,在聚类 3 中占 36%(p=0.034)。与聚类 1 相比,聚类 2 的死亡或 HF 住院风险为 1.74(95%CI,1.03-2.95,p=0.037),聚类 3 的死亡或 HF 住院风险为 1.82(95%CI,1.13-2.93,p=0.014)。

结论

聚类分析可能在产生临床上相关的 AHF 类别方面有效,并可能提示潜在的病理生理学并有助于预测临床结局。

相似文献

1
Identifying novel phenotypes of acute heart failure using cluster analysis of clinical variables.运用临床变量聚类分析识别急性心力衰竭的新表型。
Int J Cardiol. 2018 Jul 1;262:57-63. doi: 10.1016/j.ijcard.2018.03.098. Epub 2018 Mar 29.
2
Trajectory of Congestion Metrics by Ejection Fraction in Patients With Acute Heart Failure (from the Heart Failure Network).急性心力衰竭患者射血分数与充血指标的轨迹(来自心力衰竭网络)
Am J Cardiol. 2017 Jul 1;120(1):98-105. doi: 10.1016/j.amjcard.2017.03.249. Epub 2017 Apr 12.
3
Recovered heart failure with reduced ejection fraction and outcomes: a prospective study.射血分数降低的心力衰竭的恢复和结局:一项前瞻性研究。
Eur J Heart Fail. 2017 Dec;19(12):1615-1623. doi: 10.1002/ejhf.824. Epub 2017 Apr 6.
4
Factors associated with outcome in heart failure with preserved ejection fraction: findings from the Irbesartan in Heart Failure with Preserved Ejection Fraction Study (I-PRESERVE).射血分数保留的心力衰竭结局相关因素:来自 Irbesartan 在射血分数保留的心力衰竭研究(I-PRESERVE)的结果。
Circ Heart Fail. 2011 Jan;4(1):27-35. doi: 10.1161/CIRCHEARTFAILURE.109.932996. Epub 2010 Nov 10.
5
The Hospitalization Burden and Post-Hospitalization Mortality Risk in Heart Failure With Preserved Ejection Fraction: Results From the I-PRESERVE Trial (Irbesartan in Heart Failure and Preserved Ejection Fraction).射血分数保留的心力衰竭患者的住院负担和住院后死亡率风险:I-PRESERVE 试验(伊贝沙坦治疗心力衰竭和保留射血分数)的结果。
JACC Heart Fail. 2015 Jun;3(6):429-441. doi: 10.1016/j.jchf.2014.12.017. Epub 2015 May 14.
6
Phenogroups and Their Prognosis of Acute Decompensated Heart Failure with Preserved Ejection Fraction.射血分数保留的急性失代偿心力衰竭的表型及其预后。
Int Heart J. 2024 Sep 30;65(5):841-848. doi: 10.1536/ihj.24-080. Epub 2024 Sep 12.
7
Trends and predictors of non-cardiovascular death in patients hospitalized for acute heart failure.急性心力衰竭住院患者非心血管死亡的趋势和预测因素。
Int J Cardiol. 2018 Jan 1;250:164-170. doi: 10.1016/j.ijcard.2017.09.004.
8
Phenomapping for novel classification of heart failure with preserved ejection fraction.用于射血分数保留的心力衰竭新分类的表型映射
Circulation. 2015 Jan 20;131(3):269-79. doi: 10.1161/CIRCULATIONAHA.114.010637. Epub 2014 Nov 14.
9
The limited prognostic role of echocardiograms in short-term follow-up after acute decompensated heart failure: An analysis of the Korean Heart Failure (KorHF) Registry.超声心动图在急性失代偿性心力衰竭短期随访中的有限预后作用:韩国心力衰竭(KorHF)注册研究分析
PLoS One. 2017 Dec 19;12(12):e0188938. doi: 10.1371/journal.pone.0188938. eCollection 2017.
10
Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial.射血分数降低的心力衰竭住院患者中收缩压低的临床特征和预后价值:托伐普坦治疗心力衰竭的疗效、血管加压素拮抗作用和预后评估(EVEREST)试验的研究结果。
Am Heart J. 2013 Feb;165(2):216-25. doi: 10.1016/j.ahj.2012.11.004. Epub 2012 Dec 29.

引用本文的文献

1
Data Mining to Identify the Right Interventions for the Right Patient for Heart Failure: A Real-World Study.数据挖掘以确定针对心力衰竭患者的正确干预措施:一项真实世界研究。
Healthc Inform Res. 2025 Jan;31(1):66-87. doi: 10.4258/hir.2025.31.1.66. Epub 2025 Jan 31.
2
Unsupervised machine learning to identify subphenotypes among cardiac intensive care unit patients with heart failure.使用无监督机器学习识别心力衰竭心脏重症监护病房患者的亚表型。
ESC Heart Fail. 2024 Dec;11(6):4242-4256. doi: 10.1002/ehf2.15027. Epub 2024 Aug 19.
3
Sodium-glucose co-transporter 2 inhibitors in acute heart failure: real-world prescription trends and outcomes analysis.
钠-葡萄糖共转运蛋白 2 抑制剂在急性心力衰竭中的应用:真实世界处方趋势和结局分析。
ESC Heart Fail. 2024 Feb;11(1):410-421. doi: 10.1002/ehf2.14597. Epub 2023 Nov 28.
4
Identifying Premature Ventricular Complexes from Outflow Tracts Based on PVC Configuration: A Machine Learning Approach.基于室性早搏形态从流出道识别室性早搏:一种机器学习方法。
J Clin Med. 2023 Aug 26;12(17):5558. doi: 10.3390/jcm12175558.
5
Deep Learning for Echocardiography: Introduction for Clinicians and Future Vision: State-of-the-Art Review.用于超声心动图的深度学习:临床医生入门与未来展望:最新综述
Life (Basel). 2023 Apr 17;13(4):1029. doi: 10.3390/life13041029.
6
Phenomapping in heart failure with preserved ejection fraction: insights, limitations, and future directions.射血分数保留型心力衰竭的表型映射:见解、局限性和未来方向。
Cardiovasc Res. 2023 Feb 3;118(18):3403-3415. doi: 10.1093/cvr/cvac179.
7
Machine Learning Approach to Understand Worsening Renal Function in Acute Heart Failure.机器学习方法理解急性心力衰竭中肾功能恶化。
Biomolecules. 2022 Nov 2;12(11):1616. doi: 10.3390/biom12111616.
8
Identifying novel phenotypes of elevated left ventricular end diastolic pressure using hierarchical clustering of features derived from electromechanical waveform data.利用从机电波形数据得出的特征进行分层聚类,识别左心室舒张末期压力升高的新表型。
Front Cardiovasc Med. 2022 Sep 23;9:980625. doi: 10.3389/fcvm.2022.980625. eCollection 2022.
9
Arterial stiffness nomogram identification by cluster analysis: A new approach of vascular phenotype modeling.基于聚类分析的动脉僵硬度诺莫图识别:一种新的血管表型建模方法。
J Clin Hypertens (Greenwich). 2022 Nov;24(11):1415-1426. doi: 10.1111/jch.14571. Epub 2022 Oct 5.
10
Identifying novel subgroups in heart failure patients with unsupervised machine learning: A scoping review.使用无监督机器学习识别心力衰竭患者中的新亚组:一项范围综述。
Front Cardiovasc Med. 2022 Jul 22;9:895836. doi: 10.3389/fcvm.2022.895836. eCollection 2022.